Nirsevimab Greatly Reduced Severe RSV in Infants
For infants in their first RSV season, the monoclonal antibody Nirsevimab (Beyfortus) was 80% effective against RSV-related ICU admission and...
For infants in their first RSV season, the monoclonal antibody Nirsevimab (Beyfortus) was 80% effective against RSV-related ICU admission and...
What is RSV? Respiratory syncytial virus (RSV) is a common virus that affects your lungs and makes it difficult to...
Now that fall has arrived, flu season is here and the the number of people getting sick with a...
New Hampshire Department of Health and Human Services | Press releaseCONCORD— Fall is here, and the New Hampshire Department of...
Key Facts Respiratory syncytial virus (RSV) is one of the most common causes of acute lower respiratory infections in children...
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting...